Skip to main content
PMC home page
Nutrition Journal logoLink to Nutrition Journal
. 2011 Sep 26;10:98. doi: 10.1186/1475-2891-10-98

A prospective study of nutrition education and oral nutritional supplementation in patients with Alzheimer's disease

Glaucia AK Pivi 1,✉, Rosimeire V da Silva 1, Yara Juliano 2, Neil F Novo 2, Ivan H Okamoto 1, César Q Brant 1, Paulo HF Bertolucci 1
PMCID: PMC3189102  PMID: 21943331

Abstract

Background

Weight loss in patients with Alzheimer's disease (AD) is a common clinical manifestation that may have clinical significance.

Objectives

To evaluate if there is a difference between nutrition education and oral nutritional supplementation on nutritional status in patients with AD.

Methods

A randomized, prospective 6-month study which enrolled 90 subjects with probable AD aged 65 years or older divided into 3 groups: Control Group (CG) [n = 27], Education Group (EG) [n = 25], which participated in an education program and Supplementation Group (SG) [n = 26], which received two daily servings of oral nutritional supplementation. Subjects were assessed for anthropometric data (weight, height, BMI, TSF, AC and AMC), biochemical data (total protein, albumin, and total lymphocyte count), CDR (Clinical Dementia Rating), MMSE (Mini-mental state examination), as well as dependence during meals.

Results

The SG showed a significant improvement in the following anthropometric measurements: weight (H calc = 22.12, p =< 0.001), BMI (H calc = 22.12, p =< 0.001), AC (H calc = 12.99, p =< 0.002), and AMC (H calc = 8.67, p =< 0.013) compared to the CG and EG. BMI of the EG was significantly greater compared to the CG. There were significant changes in total protein (H calc = 6.17, p =< 0.046), and total lymphocyte count in the SG compared to the other groups (H cal = 7.94, p = 0.019).

Conclusion

Oral nutritional supplementation is more effective compared to nutrition education in improving nutritional status.

Keywords: supplementation, nutritional education, Alzheimer's disease

Background

Weight loss in patients with Alzheimer's disease (AD) is a common clinical manifestation. In these patients, impaired nutritional status results in changes in body composition and biochemistry indicators [1]. In order to identify such weight loss, some studies correlated organic deficiency and low energy intake or hypercatabolism in patients, thus suggesting that weight loss may be a risk factor in the etiology of dementias and other psychiatric and cognitive disorders, however this has not been evaluated [2-4]. Higher infection rates, increased energy expenditure due to repetitive movements, and cognitive deficit impairing AD patient independence may also be considered as a cause of weight loss [5,6]. Weight loss increases the risk for infections, pressure ulcer development and poor wound healing, which in turn can impair AD patient's quality of life [7].

Some strategies can be adopted to improve the nutritional status of these patients. These strategies include patient nutrition education programs, and the use of oral nutritional supplements, which can significantly impact nutritional status [8-10]. Thus, the need to study strategies of nutritional intervention which minimize or improve AD patients' nutritional status is justified, supporting the conduction of this study. The objective of this study is to determine if there is any difference between oral nutritional supplementation and nutrition education on the nutritional status of patients with AD.

Methodology

A randomized, 6-month, prospective study was conducted at the clinic of the Behavioral Neurology Sector, in the Neurology and Neurosurgery Department of Universidade Federal de São Paulo - Escola Paulista de Medicina (UNIFESP/EPM).

The sample consisted of 90 subjects, of both genders, aged at least 65 years old and with probable AD, according to Diagnostic Statistical Manual 4th Edition (DSM IV) criteria and clinical dementia rating (CDR) of 1, 2 or 3.

For exclusion criteria were considered other forms of dementia, alternative feeding requirement (tube feeding), type 1 and 2 diabetes mellitus, and renal diseases.

Twelve subjects were included in the study but not in the statistical analys is: 3 subjects from CG and 4 from EG had difficulty in being transported to the hospital; 3 subjects from SG and 1 from CG died; 1 subject from SG needed tube feeding.

The remaining subjects were randomized into 3 groups: control group (CG), (N = 27), education group (EG), (N = 25), and supplementation group (SG), (N = 26).

All subjects were assessed at baseline and then at monthly intervals during the 6-month study period, including an orientation of health nutrition. The subjects nutritional status was assessed using anthropometric and biochemical data. The anthropometric data included: height (m), current weight (kg), Body Mass Index (BMI) (kg/m2), arm circumference (AC) (cm), arm muscle circumference (AMC) (cm), and triceps skinfold (TSF) (mm). For weight were used Welmy® mechanical scales for adults with a 150 kg capacity and for height was utilized stadiometer graduated in centimeters, to for subjects that were able to maintain erect posture. For the others with presented posture problems as kyphosis or lordosis and were usable to stand, the stature and knee equation proposed by Chumlea (1985) [11] was used, to avoid biases in measures of statures. For the compartmental muscle and fat mass assessment, Lange® Skinfold calipers were used, which expresses results in millimeters (mm). The biochemistry data included: total protein (TP), serum albumin and total lymphocyte count (TLC). Biochemical data were collected following a 12-hour fast and evaluated by the central laboratory of Hospital São Paulo.

For cognitive tracking, all subjects were assessed using the Mini-Mental State Examination (MMSE) assessing temporal and spatial orientation, memory, attention, calculation, language and praxis [12,13] and Clinical Dementia Rating (CDR) [14,15] administered by a duly qualified neuropsychologist.

The following demographic data were also collected for all subjects: education level (years of schooling), time of disease evolution calculated from the date of diagnosis and dependence during meals.

Subjects in the CG were monitored by monthly nutritional assessments and did not receive any form of intervention. The 25 Subjects caregivers and patients, in the EG participated in the educational program which consisted of 10 classes. Each class was taught to a maximum of 10 participants, with the aim greater interaction between the professional and caregivers. Each expositive class was supported by slides, with themes were of data proposed in accordance with the Brazilian Association of Alzheimer's (ABRAZ) Caovilla & Canineu (2002) [16] a nonprofit association that assists caregivers and family members of patients with Alzheimer's disease. Also it took into account the information received from the caregivers based on the main nutrition deficits in AD patients. The classes were developed with relevant topics to the needs of nutritional intervention, such as: the importance of nutrition in disease, behavioral changes during meals, attractive meals, constipation, hydration, administration of drugs, swallowing, food supplementation, lack of appetite, clarification of doubts. This order of exposition follows the progression of AD and the onset of symptoms that may be related to nutrition. Subjects in the SG received oral nutritional supplementation twice daily for 6 months in addition to their usual diet (Ensure with FOS®, Abbott Nutrition) and were measured monthly by means of anthropometry and biochemical parameters, as described before. Two servings provide 680 kcal and 25.6 g protein/day.

All subjects or their representatives signed the Informed Consent Form. This research was approved by the Ethics Committee of Universidade Federal de São Paulo (protocol 0552/06).

Statistical analysis was undertook using Kruskal-Wallis variance analysis to compare the three groups in relation to anthropometric, biochemistry, demographic and disease stage variables, and Siegel's chi-square test to study possible associations between the groups and the variables studied. The rejection level of the null hypothesis was fixed at α = 0.05.

Results

Ninety (90) subjects were enrolled in the study, and 86.67% (n = 78) completed the study. Of the subjects, 30% (n = 27) were in the CG; 27.78% (n = 25) were in the EG; and 28.88% (n = 26) were in the SG. 8.89% (n = 8) of the patients did not meet the inclusion criteria and 4.44% (n = 4) died.

Of the 78 subjects who completed the study, 67.9% (n = 53) were female and 32.1% (n = 25) were male, with mean age of 75.2 years and median age of 76 years.

As shown in tables 1 and 2, 39.7% (n = 31) were in the moderate phase of the disease (CDR 2) and had a mean MMSE of 12.32, however there were no statistically significant differences among the groups. Demographic data (table 1) as well as dependence during meals (table 2) were also not statistically different among the groups. All these variables show that the groups were similar and did not have any influence on the results obtained.

Table 1.

Demographic and MMSE data of Alzheimer's Disease (AD) patients, according to Control Group (CG), Education Group (EG) and Supplementation Group (SG)

Control Education Supplementation Kruskal-Wallis variance analysis
Mean Median Mean Median Mean Median Calculated H P Significance
MMSE 12.59 18.00 12.80 12.00 11.58 9.00 0.14 0.932 N.S.
Age 75.22 74.00 75.88 76.00 76.38 78.00 0.61 0.738 N.S.
School. 3.44 3.00 5.40 4.00 4.61 4.00 3.62 0.164 N.S.
Tempev. 5.93 5.00 6.40 6.00 6.19 6.00 0.45 0.798 N.S.
Open in a new tab

MMSE: mini-mental state examination; School.: schooling in years; TEMPEV.: time of disease evolution; p: significance level; N.S.: not significant.

Table 2.

Patients with Alzheimer's Disease (AD) in Control Group (CG), Education Group (EG) and Supplementation Group (SG) compared for CDR, gender and dependence during meals

CDR Gender Dependence during Meals
1 (n) 2 (n) 3 (n) Male
(n)		 Female
(n)		 Not dep. Dep.
CG 9 9 9 7 20 14 13
EG 7 11 7 8 17 17 8
SG 7 11 8 10 16 13 13
Total 23 31 24 25 53 44 34
Open in a new tab

Critical X2 = 5.99 calculated X2 for CDR = 0.77 not significant

Critical X2 = 5.99 calculated X2 for gender = 0.96 not significant

Critical X2 = 5.99 calculated X2 for dependence during meals = 2.03 not significant

Regarding the anthropometric and biochemical parameters (Table 3), the SG showed a significant improvement in the anthropometric data of weight (H calc = 22.12, p =< 0.001), body mass index (H calc = 22.12, p =< 0.001), arm circumference (H calc = 12.99, p = 0.002), and arm muscle circumference (H calc = 8.67, p = 0.013) compared to CG and EG after 6 months. There were no statistically significant differences in TSF among the three groups after 6 months. The BMI in the EG was significant compared to CG. There were significant differences in total protein (H calc = 6.17, p = 0.046) in the SG compared to the other groups. The total lymphocyte count in the SG and EG was significant compared to the CG (H cal = 7.94, p = 0.019) after 6 months.

Table 3.

Mean and median values of anthropometric and biochemical measures for patients with Alzheimer's disease in the different groups

Control Education Supplementation Kruskal-Wallis
Mean Median Mean Median Mean Median Calculated H p Significance
Height 1.57 1.57 1.54 1.54 1.58 1.56 02.20 0.333 N.S.
CW -2.20
(61.87 - 60.65)		 -1.81
(57.60 - 55.70)		 1.19
(54.29 - 50.00)		 0.32
(54.54 - 51.70)		 6.66
(54.70 - 57.93)		 4.37
(53.55 - 56.80)		 22.12 <0.001 S > C and E
BMI -2.21
(24.81 - 24.32)		 -1.82
(23.55 - 22.80)		 1.19
(22.71 - 22.84)		 0.31
(23.82 - 23.90)		 6.55
(21.66 - 22.98)		 4.37
(22.38 - 23.15)		 21.94 <0.001 S > C and E
AC -0.41
(26.14 - 26.07)		 0.00
(26.40 - 26.30)		 1.87
(24.72 - 25.11)		 2.34
(25.60 - 26.00)		 5.44
(23.99 - 25.20)		 4.76
(23.90 - 24.80)		 12.99 0.002 S > C and E
TSF 2.20
(15.67 - 15.85)		 0.00
(15.00 - 16.00)		 2.32
(14.20 - 16.40)		 1.00
(14.00 - 16.00)		 1.44
(11.54 - 13.55)		 1.58
(12.00 - 14.00)		 3.98 0.136 N.S.
AMC -0.19
(21.21 - 21.60)		 -0.90
(21.12 - 21.01)		 -1.27
(20.25 - 19.96)		 -2.06
(19.80 - 19.66)		 3.43
(20.36 - 21.01)		 2.54
(20.44 - 20.93)		 8.67 0.013 S > C and E
Total prot. 0.09
(06.94 - 06.95)		 0.00
(07.00 - 06.90)		 -1.04
(06.55 - 06.84)		 -1.39
(06.80 - 06.80)		 4.30
(06.46 - 07.02)		 3.28
(06.8 - 07.00)		 6.17 0.046 S > C and E
Albumin -3.15
(04.31 - 04.17)		 -4.35
(04.30 - 04.10)		 -4.06
(04.05 - 04.08)		 -4.54
(04.20 - 04.20)		 0.69
(03.81 - 04.07)		 0.00
(04.20 - 04.20)		 2.54 0.281 N.S.
TLC 13.43
(2045.24 - 2279.46)		 10.50
(2034.35 - 2416.04)		 -1.06
(1888.85 - 1835.25)		 -1.41
(1852.40 - 1806.12)		 12.57
(1464.20 - 1808.68)		 10.68
(1541.10 - 1582.50)		 7.94 0.019 S and E > C
Open in a new tab

CW = Current Weight (kg); BMI = Body Mass Index (Kg/m2); AC = Arm Circumference (cm); TSF = Triceps Skin fold (mm) and AMC = Arm Muscle Circumference (cm); Total prot. = total serum protein (μg/dl); TLC = Total Lymphocyte Count (mm3); p: significance level; N.S. = not significant

There were no statistically significant differences in serum albumin among the three groups.

Discussion

Most subjects studied had CDR 2, which is relevant since most feeding behavior changes, such as forgetfulness or feeding voracity, are seen in this phase of the disease [17].

In the EG, BMI showed a significant increase compared to CG (p < 0.001). Likewise, biochemical (TP and TLC, p = 0.046, p = 0.019 respectively) and anthropometric indicators (AC and AMC, p = 0.002 and p = 0.013 respectively) also improved in EG group. Our results support the findings from other studies, showing that nutritional education has a positive effect on the diet and modifies nutrition knowledge [18,7,19].

There were significant differences in the SG's anthropometric measures (current weight, BMI, AC, AMC) compared to CG and EG, showing that the use of oral nutritional supplementation improves the patient's nutritional status. In addition, since there were no significant differences in TSF measurement among the three groups, and particularly in the SG, showed that there was no increase in subcutaneous body fat. Furthermore, the oral nutritional supplementation did not result in significant difference in TSF measurement among the three groups, indicating that additional oral nutritional supplementation did not increase subcutaneous body fat in this sample.

Oral nutritional supplementation provided to dementia patients significantly improves nutritional status and the quality of the diet consumed [20,21], but despite these results, Trelis & López [22] observed that only 11% of outpatients used oral nutritional supplements.

In Brazil, there are no studies of outpatients using any type of oral nutritional supplements. However, this study clearly indicates that it is important for all health care professionals involved in the treatment of patients with AD to be able to detect the presence of nutritional deficits. This enables health care professionals to refer the patient to a qualified health professional, so the best nutritional intervention can be implemented.

The benefits of using oral nutritional supplementation have also been studied in elderly subjects without dementia and have shown their efficacy in addition to usual diet. The addition of 500 kcal/day via oral nutritional supplementation for elderly has been shown to improve convalescence and recovery from deficiency states [23,24].

In relation to the biochemical parameters used to assess nutritional status, significant differences were only seen for total protein in the SG and total lymphocyte count in the SG and EG.

Increased total protein in the SG was not correlated with the use of oral nutritional supplementation, but this result may be correlated with evolution of the disease itself. This parameter could perhaps be better assessed with a larger sample or longer follow up.

Increased total lymphocyte count (TLC) in the EG suggests that nutrition education might contribute to the improvement in the immune status of the patients. This may be due to the influence of education on the choice of healthier food, which contributes to the nutritional status as a whole [25].

On the other hand, the significant improvement in TLC in SG subjects showed that the use of oral nutritional supplementation improves immune status. This may be due to the antioxidant micronutrients in the supplement, particularly selenium, β-carotene, vitamin C and E, which impact with the immune system [26,27].

Improving or maintaining the nutritional status of patients with AD should be a priority of patient treatment. Therefore this is a responsibility for the entire multiprofessional team.

Implementing nutrition education improved the BMI of patients with AD, and thus its use is viable for any kind of healthcare service due to its low cost and positive impact on the modification of dietary habits. In addition, oral nutritional supplementation should be part of the usual diet of these patients, as the additional nutrients provided contribute to an improved nutritional status [28,29].

Conclusion

Oral nutritional supplementation was shown to be more effective compared to nutrition education in improving nutritional status of patients with Alzheimer's Disease.

List of abbreviations

ABRAZ: Brazilian Association of Alzheimer's; AC: Arm Circumference; AD: Alzheimer's Disease; AMC: Arm muscle circumference; BMI: Body Mass Index; CDR: Clinical Dementia Rating; CG: Control Group; DSM IV: Diagnostic Statistical Manual 4th Edition; EG: Education Group; FOS: Fructooligosaccharides; g: gram; Kcal: calorie; Kg: kilogram; Kg/m2: kilogram/meter; mm: millimeters; MMSE: Mini-Mental State Examination; SG: Supplementation Group; TLC: Total Lymphocyte Count; TP: Total protein; TSF: Triceps skinfold;

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

GP gave classes, nutritional orientations and antropometric measures in all sample, writing of the article and critically reviewed the article. RS participated of protocol desing, did cognitive measures and reviewed the manuscript. YJ and NN carried out of the statistical analysis. IO was responsible for DA diagnostics. CQ and PH was involved in the protocol and the study desing, analysis and writing of the article. All authors read and approved the final manuscript.

Contributor Information

Glaucia AK Pivi, Email: glauciapivi@hotmail.com.

Rosimeire V da Silva, Email: psicorosi@terra.com.br.

Yara Juliano, Email: bertolucci.paulo@unifesp.br.

Neil F Novo, Email: bertolucci.paulo@unifesp.br.

Ivan H Okamoto, Email: hideyo@sti.com.br.

César Q Brant, Email: cesarbrant@uol.com.br.

Paulo HF Bertolucci, Email: bertolucci.paulo@unifesp.br.

Acknowledgements

We want to acknowledge: CAPES - Ministry of Education and Abbott Laboratories for their contribution to the realization of this work and the opportunity given to provide all supplementation that was distributed to all patients freely.

References

  1. Contreras AT. Nutrición em la enfermedad de Alzheimer. Arch Neurocien. 2004;10(9):151–158. [Google Scholar]
  2. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ. Wheight loss precedes dementia community-dwelling older adults. J Am Geriatr Soc. 1996;10:1147–1152. doi: 10.1111/j.1532-5415.1996.tb01362.x. [DOI] [PubMed] [Google Scholar]
  3. Reyes-Ortega G, Guyonnet S, Ousset PJ, Nourhashemi F, Vellas B, Albarède JL, De Glizezinski I, Riviere D, Fitten LJ. Weight loss in Alzheimer's disease and resting energy expenditure (REE), a preliminary report. J Am Geriatr Soc. 1997;10(11):1365–70. doi: 10.1111/j.1532-5415.1997.tb02953.x. [DOI] [PubMed] [Google Scholar]
  4. Poehlman ET, Dvorak RV. Energy expenditure, energy intake, and weight loss in Alzheimer disease. Am J Clin Nutr. 2000. pp. 650S–655S. [DOI] [PubMed]
  5. DiLuca DuW, Growden JH. Weight loss in. Alzheimer's Disease. J Geriatric Psychiatry Neurol. 1993;10:34–38. doi: 10.1177/002383099300600106. [DOI] [PubMed] [Google Scholar]
  6. Kikuchi EL, Filho WJ. In: Demência Abordagem Multidisciplinar. Caixeta L, editor. São Paulo: Atheneu; 2006. Tratamento e prevenção de Distúrbios Físicos associados; pp. 531–538. [Google Scholar]
  7. Riviere S. Program of nutritional education in the prevention of weight loss and slow cognitive decline in the disease of Alzheimer. J Nutr Health Aging. 2001. pp. 295–99. [PubMed]
  8. Turano W, Almeida CCC. Nutrição Saúde e Comunidade. 2. Rio de Janeiro: Revinter; 1999. Educação Nutricional. In: Gouveia ELC; pp. 57–60. [Google Scholar]
  9. Burns BL, Davis EMC. Alimentos, Nutrição e Dietoterapia. 9. São Paulo: Roca; 1998. Cuidado Nutricional nas Doenças do Sistema Nervoso. In:Mahan LK, Stump SE; pp. 896–7. [Google Scholar]
  10. Borges VC. Nutrição Total. São Paulo. Disponível em; 2003. Repercussão Nutricional nas Doenças Neurológicas da Velhice: Alzheimer e Parkinson. [texto na internet]http://www.nutritotal.com.br [Google Scholar]
  11. Chumlea WC, Roche AF, Steinbaugh ML. Estimating stature from knee height for persons 60 to 90 years of age. J Am Geriatric Soc. 1985. pp. 116–120. [DOI] [PubMed]
  12. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;10:189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  13. Bertolucci PHF, Brucki SMD, Campacci SR, Juliano Y. O mini-exame do Estado Mental em uma população geral. Impacto da escolaridade. Arq Neuropsiq. 1994;10:1–7. doi: 10.1590/S0004-282X1994000100001. [DOI] [PubMed] [Google Scholar]
  14. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the stating of dementia. British Journal of Psychiatry. 1982;10:556–572. doi: 10.1192/bjp.140.6.566. [DOI] [PubMed] [Google Scholar]
  15. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;10:2412–2414. doi: 10.1212/wnl.43.11.2412-a. [DOI] [PubMed] [Google Scholar]
  16. Caovilla VP, Canineu PR. Você não está sozinho. ABRAZ. São Paulo: ABRAZ; 2002. [Google Scholar]
  17. Muñoz AM, Agudelo GM, Lopera FJ. Diagnóstico del estado nutricional de los pacientes con demencia tipo Alzheimer registrados en el Grupo de Neurocienciais, Medellín, 2004. Biomédica. 2006;10(26):113–125. [PubMed] [Google Scholar]
  18. Boog MCF. Educação nutricional em serviços públicos de saúde. Cad Saúde Pública. 1999;10(15):S139–S147. [PubMed] [Google Scholar]
  19. Cervato AM, Dernti AM, Latorre MRDO, Marucci MFN. Educação nutricional para adultos: uma experiência positiva em Universidade Aberta para a Terceira Idade. Rev Nutr. 2005;10(1):41–52. doi: 10.1590/S1415-52732005000100004. [DOI] [Google Scholar]
  20. Carver AD, Dobson AM. Effects of dietary supplementation of elderly demented hospital residents. J hum Nutr Diet. 1995. pp. 389–94.
  21. Faxen-Irving G, Andren-Olsson B, Geirjerstam AF, Basun H, Cederholm T. The effect of nutritional intervention in elderly subjects residing in group-living for the demented. Eur Jour of clinical. 2002;10(3):221–27. doi: 10.1038/sj.ejcn.1601304. [DOI] [PubMed] [Google Scholar]
  22. Trelis JJB, López IF. La Alimentación del enfermo de Alzheimer en el âmbito familiar. Nutr Hosp. 2004. pp. 154–59. [PubMed]
  23. Lauque S, Battandier FA, Mansourian R, Guigoz Y, Paintin M. Nourhashemi F, et al. Protein-energy oral supplementation in malnourished nursing-home residents. A controlled trial. Age and Ageing. 2000. pp. 51–6. [DOI] [PubMed]
  24. Volkert D, Hubsch S, Oster P. Nutritional support and functional status in undernourished geriatric patients during hospitalization and 6 months follow-up. Aging Clin Exp Res. 1996. pp. 386–95. [DOI] [PubMed]
  25. Norregaard O, Tottrup A, Saaek A. Effects of oral nutritional supplements on adults with chronic obstructive pulmonary disease. Clin Resp Physiol. 1987. p. 388.
  26. Sampaio ARD, Mannarino IC. In: Avaliação Nutricional: Aspectos Clínicos e Laboratoriais. Duarte ACG, editor. São Paulo: Atheneu; 2007. Medidas bioquímicas de avaliação do estado nutricional; pp. 69–73. [Google Scholar]
  27. Roebothan BV, Chandra RK. Relationship between Nutritional Status and Immune Function of Elderly People. Age Ageing. 1994. pp. 49–53. [DOI] [PubMed]
  28. Spindler AA, Renvall MJ, Nichols JF, Ramsdell JW. Nutritional Status of Patients with Alzheimer's Disease: A 1-Year Study. J AM Diet Assoc. 1996;10(96):1013–1018. doi: 10.1016/S0002-8223(96)00270-2. [DOI] [PubMed] [Google Scholar]
  29. Fonseca AM Soares E Interdisciplinaridade em grupos de apoio a Familiares e Cuidadores do Portador da Doença de Alzheimer Rev Saúde Com 20071013–11.21919980 [Google Scholar]

Articles from Nutrition Journal are provided here courtesy of BMC

RESOURCES